Pen Needles

Global Pen Needles Market to Reach US$4.8 Billion by 2030

The global market for Pen Needles estimated at US$2.8 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Standard, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Safety segment is estimated at 11.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$913.6 Million While China is Forecast to Grow at 10.3% CAGR

The Pen Needles market in the U.S. is estimated at US$913.6 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$381.7 Million by the year 2030 trailing a CAGR of 10.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.9% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Pen Needles Market - Key Trends & Drivers Summarized

Pen needles are essential components used with injection pens to deliver medications such as insulin, growth hormones, and other therapeutic agents. These needles are designed to be attached to the pen device, providing a convenient and precise method for administering subcutaneous injections. Pen needles come in various lengths and gauges, allowing patients and healthcare providers to select the most appropriate needle for different injection sites and patient needs. The design of pen needles focuses on minimizing pain and discomfort during injections, with features such as ultra-thin walls, fine tips, and lubricated coatings. This makes pen needles particularly suitable for patients requiring frequent injections, such as those with diabetes who need regular insulin administration.

Technological advancements have led to significant improvements in the design and functionality of pen needles. Modern pen needles incorporate advanced manufacturing techniques that enhance sharpness and reduce penetration force, resulting in less painful injections. Innovations such as safety pen needles, which feature built-in shields to prevent needlestick injuries, have improved safety for both patients and healthcare providers. Additionally, the development of shorter and finer needles has made injections less intimidating and more comfortable, encouraging better adherence to treatment regimens. The use of high-quality materials ensures the durability and reliability of pen needles, providing consistent performance with each use. These advancements have expanded the adoption of pen needles across various therapeutic areas, making them a preferred choice for medication delivery.

The growth in the pen needles market is driven by several factors, including the rising prevalence of diabetes, increasing adoption of self-administration of medications, and advancements in needle technology. The global increase in diabetes cases has significantly boosted the demand for insulin delivery devices, including pen needles. The trend towards self-administration of medications, driven by patient convenience and the need for regular therapy, has further fueled market growth. Technological advancements, such as the development of safety and ultra-fine pen needles, have enhanced the safety and comfort of injections, encouraging broader adoption among patients. Additionally, the increasing availability of pen needles in various lengths and gauges has provided more options for personalized treatment, catering to diverse patient needs. Government initiatives and healthcare policies promoting diabetes management and the use of advanced drug delivery systems are also contributing to the growth of the pen needles market.

SCOPE OF STUDY:

The report analyzes the Pen Needles market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Standard, Safety); Therapy (Insulin, Glucagon-Like Peptide-1 (GLP-1), Other Therapies)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 63 Featured) -

• Advin Health Care
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Cipla Ltd.
• ARKRAY, Inc.
• Gerresheimer AG
• A. Menarini Diagnostics Srl
• Exelint International Co.
• Hindustan Syringes & Medical Devices Ltd.
• Allison Medical, Inc.
• HTL-Strefa SA
• GlucoRx Ltd.
• Cambridge Sensors Ltd.
• Igaku Needles Private Limited
• AdvaCare Pharma

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.